Company:  ANIXA BIOSCIENCES INC (ANIX)
Form Type:  4
Filing Date:  1/14/2020 
CIK:  0000715446 
Address:  3150 ALMADEN EXPRESSWAY, SUITE 250 
City, State, Zip:  SAN JOSE, California 95118 
Telephone:  408-708-9808 
Fiscal Year:  10/31 
Last Trade
Last Trade: 
$2.24  
Change: 
-0.13 (-5.49%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$47.06M
Trade ANIX now with 

© 2020  
Description of Business
Anixa Biosciences, Inc. is a biotechnology company focused on using the body's immune system to diagnose, treat and prevent cancer. We were incorporated on November 5, 1982 under the laws of the State of Delaware. Effective October 1, 2018, the Company changed its name from ITUS Corporation to Anixa Biosciences, Inc. From inception through October 2012, our primary operations involved the development of patented technologies in the areas of thin-film displays and encryption. From October 2012 through June 2015, the primary operations of the Company involved the development, acquisition, licensing, and enforcement of patented technologies that were either owned or controlled by the Company. In June 2015, we formed a subsidiary, Anixa Diagnostics Corporation ("Anixa Diagnostics"), to develop Cchek(TM) a platform for non-invasive blood tests for the early detection of cancer.
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    REPORTING OWNERS
    SIGNATURES